Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes.
Guo
Z
Z
Department of General Surgery, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA.
Mital
D
D
Shen
J
J
Chong
A S
AS
Tian
Y
Y
Foster
P
P
Sankary
H
H
McChesney
L
L
Jensik
S C
SC
Williams
J W
JW
D000818:Animals; D015551:Autoimmunity / Q000187:drug effects*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000473:pathology / Q000517:prevention & control / Q000601:surgery*; D006084:Graft Rejection / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016381:Islets of Langerhans Transplantation; D007555:Isoxazoles / Q000008:administration & dosage*; D000077339:Leflunomide; D051379:Mice; D016688:Mice, Inbred NOD; D051381:Rats; D017207:Rats, Sprague-Dawley; D012008:Recurrence; D014183:Transplantation, Heterologous
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide